Gastroretentive Drug Delivery Systems Market Worth $19.7 Billion By 2028
Gastroretentive Drug Delivery Systems Industry Overview
The global gastroretentive drug delivery systems market size is estimated to reach USD 19.7 billion by 2028, registering a CAGR of 6.4%, according to a new report by Grand View Research, Inc. Gastroretentive Drug Delivery Systems (DDSs) offer possible advantages for the drug with poor bioavailability, as their absorption is restricted to the upper Gastrointestinal Tract (GIT) and can be delivered proficiently. Hence enhancing absolute bioavailability and maximizing its absorption is expected to boost market growth during the forecast period.
Several advantages of these DDSs include curative efficiency and an increase in the bioavailability of drugs. The controlled and systematic DDS minimizes the chances of medicine overexposure at the diseased site. It also offers higher efficiency owing to reduced counter activity by the body. Hence, various advantages associated with gastroretentive DDSs are expected to foster the overall market progression.
The DDS sustains the release of drugs and avails local therapy in the small intestine and stomach. The method is useful in the treatment of various disorders related to the small intestine and stomach. Rising cases of stomach and small intestine-related disorders are anticipated to foster the demand for such efficient DDSs. According to the Endoscopy Center, each year around 62.0 million people are diagnosed with digestive disorders. The prevalence of most digestive disorders increases with age, creating demand for novel healthcare systems among adults and the geriatric population.
These DDSs are effective in treating duodenal and gastric ulcers, including esophagitis, by eliminating deeply buried helicobacter pylori from the submucosal tissue of the stomach. Apart from this, GRDDSs release the medicine slowly in the stomach and preserve its effective concentration in systemic circulation for a prolonged period of time. Hence, the above-mentioned factors are predicted to augment market expansion.
Gastroretentive Drug Delivery Systems Market Segmentation
Grand View Research has segmented the global gastroretentive drug delivery systems market on the basis of type, dosage form, distribution channel, and region:
Based on the Type Insights, the market is segmented into High Density Systems, Expandable Drug Delivery Systems, Bioadhesive Drug Delivery Systems, Floating Drug Delivery Systems, and Others.
- The floating drug delivery systems segment accounted for the largest revenue share of 46.0% in 2020. Floating drug delivery systems is one of the important methods to attain gastric retention to gain adequate drug bioavailability. This system has less bulk density than gastric fluids and thus stays buoyant in the stomach without disturbing gastric emptying rate for a sustained period.
- The bioadhesive drug delivery systems segment is expected to witness a healthy CAGR of 7.1% over the forecast period. Bioadhesivepolymers are used in enhancing drug absorption and can adhere to the epithelial surface in the stomach. Thus, they improve the gastric retention prolongation, thereby increasing its adoption rate.
Based on the Dosage Form Insights, the market is segmented into Tablets, Liquid, Microspheres, Capsule, and Others.
- The tablets segment dominated the market for gastroretentive drug delivery systems and accounted for the largest revenue share of 38.5% in 2020. The increasing focus of manufacturers on developing gastroretentive tablets is expected to maintain a strong position in the market.
- The capsule dosage form segment had a considerable revenue share in 2020. Various key players are manufacturing capsule-based gastroretentive products owing to their increased efficiency. Manufacturers such as Roche, Pfizer are producing controlled-release capsules and bilayer floating capsules respectively.
Based on the Distribution Channel Insights, the market is segmented into Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies.
- The hospital pharmacies segment dominated the market for gastroretentive drug delivery systems and captured the largest revenue share of 34.9% in 2020. Hospital pharmacies preserve the stock of products related to gastric disorders for in-patients and out-patients.
- The online pharmacies segment is predicted to be the fastest-growing distribution channel segment and is expected to witness a CAGR of 7.7% over the forecast period. This growth can be accredited to convenience and user-friendly interfaces offered by online pharmacies in terms of prices, delivery, and access.
Gastroretentive DDS Regional Outlook
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa (MEA)
Key Companies Profile & Market Share Insights
Product launch, strategic acquisitions, and innovation are major strategies adopted by the market players to retain their market share. Some of the prominent players in the gastroretentive drug delivery systems (DDSs) market include:
- Hoffmann La Roche
- Ranbaxy
- GlaxoSmithKline
- Pharmacia
- Depomed
- Alcon, Inc.
- Lupin
- Galanix
- Sun Pharma
Order a free sample PDF of the Gastroretentive Drug Delivery Systems Market Intelligence Study, published by Grand View Research.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Comments
Post a Comment